McLaughlin P, De la Corte-Rodriguez H, Burke T, Nissen F, Aizenas M, Moreno K
Orphanet J Rare Dis. 2025; 20(1):18.
PMID: 39806420
PMC: 11726912.
DOI: 10.1186/s13023-024-03514-1.
Dunn A, Dargaud Y, Abajas Y, Carcao M, Castaman G, Giermasz A
Haemophilia. 2024; 31(1):78-86.
PMID: 39676340
PMC: 11780187.
DOI: 10.1111/hae.15109.
Meijon Ortigueira M, Alvarez-Roman M, De La Corte Rodriguez H, Butta Coll N, Jimenez-Yuste V
Res Pract Thromb Haemost. 2023; 7(1):100005.
PMID: 36891521
PMC: 9986103.
DOI: 10.1016/j.rpth.2022.100005.
Yang R, Wang S, Wang X, Sun J, Chuansumrit A, Zhou J
Res Pract Thromb Haemost. 2022; 6(2):e12670.
PMID: 35284778
PMC: 8902287.
DOI: 10.1002/rth2.12670.
Abdi A, Eckhardt C, van Velzen A, Vuong C, Coppens M, Castaman G
J Thromb Haemost. 2021; 19(9):2171-2181.
PMID: 34107158
PMC: 8457239.
DOI: 10.1111/jth.15419.
The factor VIII treatment history of non-severe hemophilia A.
Abdi A, Kloosterman F, Eckhardt C, Male C, Castaman G, Fischer K
J Thromb Haemost. 2020; 18(12):3203-3210.
PMID: 32877570
PMC: 7756346.
DOI: 10.1111/jth.15076.
Low Dose Prophylaxis in Hemophilia Care.
Sidharthan N, Sudevan R
Indian J Hematol Blood Transfus. 2020; 36(1):16-25.
PMID: 32158085
PMC: 7042432.
DOI: 10.1007/s12288-019-01147-0.
Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study.
Zanon E, Tagliaferri A, Pasca S, Ettorre C, Notarangelo L, Biasioli C
Blood Transfus. 2019; 18(2):152-158.
PMID: 31184581
PMC: 7141936.
DOI: 10.2450/2019.0040-19.
The relationship between target joints and direct resource use in severe haemophilia.
OHara J, Walsh S, Camp C, Mazza G, Carroll L, Hoxer C
Health Econ Rev. 2018; 8(1):1.
PMID: 29340855
PMC: 5770351.
DOI: 10.1186/s13561-018-0185-7.
Analysis of a paediatric orthopaedic network: a six-year experience in the South West of the United Kingdom.
Bruce D, Kocialkowski C, Bintcliffe F, Monsell F, Barnes J, Brown R
J Child Orthop. 2017; 11(5):404-413.
PMID: 29081857
PMC: 5643936.
DOI: 10.1302/1863-2548.11.170076.
Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed.
Berger K, Feldman B, Wasserman J, Schramm W, Blanchette V, Fischer K
Haematologica. 2016; 101(3):266-8.
PMID: 26928247
PMC: 4815717.
DOI: 10.3324/haematol.2015.139931.
Using value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.
Abrahamyan L, Willan A, Beyene J, Mclimont M, Blanchette V, Feldman B
J Gen Intern Med. 2014; 29 Suppl 3:S767-73.
PMID: 25029970
PMC: 4124117.
DOI: 10.1007/s11606-014-2880-3.
Current and evolving features in the clinical management of haemophilia.
Coppola A, Morfini M, Cimino E, Tufano A, Cerbone A, Di Minno G
Blood Transfus. 2014; 12 Suppl 3:s554-62.
PMID: 24922295
PMC: 4044810.
DOI: 10.2450/2014.0043-14s.
Musculoskeletal evaluation in severe haemophilia A patients from Latin America.
Ozelo M, Villaca P, Perez-Bianco R, Candela M, Garcia-Chavez J, Moreno-Rodriguez B
Haemophilia. 2013; 20(1):e63-70.
PMID: 24354487
PMC: 4285291.
DOI: 10.1111/hae.12316.
Issues in pediatric haemophilia care.
Giordano P, Franchini M, Lassandro G, Faienza M, Valente R, Molinari A
Ital J Pediatr. 2013; 39:24.
PMID: 23601343
PMC: 3651319.
DOI: 10.1186/1824-7288-39-24.
Target of prophylaxis in severe haemophilia: more than factor levels.
Coppola A, Franchini M
Blood Transfus. 2013; 11(3):327-9.
PMID: 23356974
PMC: 3729119.
DOI: 10.2450/2012.0244-12.
Past, present and future of hemophilia: a narrative review.
Franchini M, Mannucci P
Orphanet J Rare Dis. 2012; 7:24.
PMID: 22551339
PMC: 3502605.
DOI: 10.1186/1750-1172-7-24.
Treatment of hemophilia: a review of current advances and ongoing issues.
Coppola A, Di Capua M, Di Minno M, Di Palo M, Marrone E, Ierano P
J Blood Med. 2012; 1:183-95.
PMID: 22282697
PMC: 3262316.
DOI: 10.2147/JBM.S6885.
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A.
Colombo G, Di Matteo S, Mancuso M, Santagostino E
Clinicoecon Outcomes Res. 2011; 3:55-61.
PMID: 21935333
PMC: 3169977.
DOI: 10.2147/CEOR.S16670.
The influence of prophylactic factor VIII in severe haemophilia A.
Gissel M, Whelihan M, Ferris L, Mann K, Rivard G, Brummel-Ziedins K
Haemophilia. 2011; 18(2):193-9.
PMID: 21899664
PMC: 3778653.
DOI: 10.1111/j.1365-2516.2011.02638.x.
